Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism

Schizophrenia Research

Volumn 97, Issue 1-3, 2007, Pages 254-263

  Braun, Isabella ^a   Genius, Just ^a   Grunze, Heinz ^a   Bender, Andreas ^a   Möller, Hans Jürgen ^a   Rujescu, Dan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Haloperidol; Interneurons; Limbic system; MK 801; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DIZOCILPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GABAERGIC SYSTEM; HIPPOCAMPUS; IMMUNOREACTIVITY; INTERNEURON; MALE; NEUROPATHOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; SCHIZOPHRENIA; STAINING; SYMPTOMATOLOGY;

ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GAMMA-AMINOBUTYRIC ACID; HALOPERIDOL; HIPPOCAMPUS; INTERNEURONS; MALE; NEURAL INHIBITION; NEURONS; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 36048979320     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.05.005     Document Type: Article

References (47)

1. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney Jr. W.E., and Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry 53 (1996) 425-436
2. Arvanov V.L., and Wang R.Y. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-d-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro. Neuropsychopharmacology 18 (1998) 197-209
3. Baba H., Suzuki T., Arai H., and Emson P.C. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 15 (2004) 677-680
4. Beasley C.L., and Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24 (1997) 349-355
5. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
6. Cahir M., Costello I., King D.J., and Reynolds G.P. Chronic haloperidol or clozapine treatment does not alter parvalbumin immunoreactivity in the rat frontal cortex or hippocampus. Neurosci. Lett. 373 (2005) 57-60
7. Cobb S.R., Buhl E.H., Halasy K., Paulsen O., and Somogyi P. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378 (1995) 75-78
8. Cochran S.M., Kennedy M., McKerchar C.E., Steward L.J., Pratt J.A., and Morris B.J. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28 (2003) 265-275
9. Danos P., Baumann B., Bernstein H.G., Franz M., Stauch R., Northoff G., Krell D., Falkai P., and Bogerts B. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res. 82 1 (1998) 1-10
10. Dawson T.M., and Snyder S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14 (1994) 5147-5159
11. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuroanat. 14 (1997) 1-19
12. Diamond A., Zola-Morgan S., and Squire L.R. Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants. Behav. Neurosci. 103 (1989) 526-537
13. Gabbott P.L., Dickie B.G., Vaid R.R., Headlam A.J., and Bacon S.J. Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: morphology and quantitative distribution. J. Comp. Neurol. 377 (1997) 465-499
14. Goldberg J.H., Yuste R., and Tamas G. Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+ dynamics. J. Physiol. 551 (2003) 67-78
15. Gorelova N., Seamans J.K., and Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J. Neurophysiol. 88 (2002) 3150-3166
16. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., and Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16 (1996) 2034-2043
17. Healy D.J., and Meador-Woodruff J.H. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res. 708 (1996) 38-44
18. Hope B.T., and Vincent S.R. Histochemical characterization of neuronal NADPH-diaphorase. J. Histochem. Cytochem. 37 (1989) 653-661
19. Hope B.T., Michael G.J., Knigge K.M., and Vincent S.R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. U. S.A. 88 (1991) 2811-2814
20. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
21. Jiang M., and Swann J.W. Expression of calretinin in diverse neuronal populations during development of rat hippocampus. Neuroscience 81 (1997) 1137-1154
22. Kawaguchi Y., and Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb. Cortex 7 (1997) 476-486
23. Keilhoff G., Becker A., Grecksch G., Wolf G., and Bernstein H.G. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 126 (2004) 591-598
24. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., and Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25 (2001) 455-467
25. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev., Neurosci. 6 (2005) 312-324
26. Lidow M.S., and Goldman-Rakic P.S. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4353-4356
27. Lidow M.S., Elsworth J.D., and Goldman-Rakic P.S. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 281 (1997) 597-603
28. Miles R., Toth K., Gulyas A.I., Hajos N., and Freund T.F. Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16 (1996) 815-823
29. Ninan I., Jardemark K.E., and Wang R.Y. Differential effects of atypical and typical antipsychotic drugs on N-methyl-d-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex. Synapse 48 (2003) 66-79
30. Nomura T., Fukuda T., Aika Y., Heizmann C.W., Emson P.C., Kobayashi T., and Kosaka T. Laminar distribution of non-principal neurons in the rat hippocampus, with special reference to their compositional difference among layers. Brain Res. 764 (1997) 197-204
31. Oades R.D. Impairments of search behaviour in rats after haloperidol treatment, hippocampal or neocortical damage suggest a mesocorticolimbic role in cognition. Biol. Psychol. 12 (1981) 77-85
32. Paxinos G., Watson C.R., and Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J. Neurosci. Methods 3 (1980) 129-149
33. Rao S.G., Williams G.V., and Goldman-Rakic P.S. Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J. Neurophysiol. 81 4 (1999) 1903-1916
34. Reynolds G.P., and Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia. J. Chem. Neuroanat. 22 (2001) 95-100
35. Reynolds G.P., Zhang Z.J., and Beasley C.L. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res. Bull. 55 (2001) 579-584
36. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., Giegling I., Genius J., McCarley R.W., Moller H.J., and Grunze H. A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol. Psychiatry 59 (2006) 721-729
37. Schroeder U., Schroeder H., Schwegler H., and Sabel B.A. Neuroleptics ameliorate phencyclidine-induced impairments short-term memory. Br. J. Pharmacol. 130 1 (2000) 33-40
38. Tooney P.A., and Chahl L.A. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 273-278
39. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57 (2005) 252-260
40. Tseng K.Y., and O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J. Neurosci. 24 (2004) 5131-5139
41. Tseng K.Y., Mallet N., Toreson K.L., Le Moine C., Gonon F., and O'Donnell P. Excitatory response of prefrontal cortical fast-spiking interneurons to ventral tegmental area stimulation in vivo. Synapse 59 (2006) 412-417
42. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., and Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc. Natl. Acad. Sci. U. S. A. 83 18 (1986) 7104-7108
43. Woo T.U., Miller J.L., and Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am. J. Psychiatry 154 (1997) 1013-1015
44. Xing G., Chavko M., Zhang L.X., Yang S., and Post R.M. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr. Res. 58 (2002) 21-30
45. Yamamoto B.K., and Cooperman M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14 (1994) 4159-4166
46. Yanik M., Vural H., Kocyigit A., Tutkun H., Zoroglu S.S., Herken H., Savas H.A., Koylu A., and Akyol O. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?. Neuropsychobiology 47 (2003) 61-65
47. Zhang Z.J., and Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr. Res. 55 (2002) 1-10